These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 22165684)
1. The incidence of non-proliferative and precancerous lesions of reduction mammoplasty: evaluation of 273 cases. Samdanci ET; Firat C; Cakir E; Ak M; Sayin S; Nurkabul Z Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1207-11. PubMed ID: 22165684 [TBL] [Abstract][Full Text] [Related]
2. Incidental atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer. Li Z; Fadare O; Hameed O; Zhao C; Desouki MM Hum Pathol; 2014 Jan; 45(1):104-9. PubMed ID: 24182561 [TBL] [Abstract][Full Text] [Related]
3. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers. Desouki MM; Li Z; Hameed O; Fadare O; Zhao C Hum Pathol; 2013 Sep; 44(9):1877-81. PubMed ID: 23656973 [TBL] [Abstract][Full Text] [Related]
4. Reduction mammaplasty specimens and occult breast carcinomas. Kakagia D; Fragia K; Grekou A; Tsoutsos D Eur J Surg Oncol; 2005 Feb; 31(1):19-21. PubMed ID: 15642421 [TBL] [Abstract][Full Text] [Related]
5. Pathologic findings in breast reduction specimens: detection of occult premalignant and cancerous lesions. Kyriopoulos E; Kakagia D; Zapandioti P; Papaliodi E; Tsoutsos D Onkologie; 2012; 35(10):583-6. PubMed ID: 23038229 [TBL] [Abstract][Full Text] [Related]
6. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions. Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687 [TBL] [Abstract][Full Text] [Related]
8. Histological findings in breast tissue specimens from reduction mammoplasties. Karabela-Bouropoulou V; Liapi-Avgeri G; Iliopoulou E; Agnantis NJ Pathol Res Pract; 1994 Sep; 190(8):792-8. PubMed ID: 7831156 [TBL] [Abstract][Full Text] [Related]
9. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964 [TBL] [Abstract][Full Text] [Related]
10. Frequency of clinically occult intraepithelial and invasive neoplasia in reduction mammoplasty specimens: a study of 516 cases. Dotto J; Kluk M; Geramizadeh B; Tavassoli FA Int J Surg Pathol; 2008 Jan; 16(1):25-30. PubMed ID: 18203780 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of incidence and histolopathological findings of breast lesions in reduction mammoplasty specimens: Uludag University experience. Aytac B; Sahsine T; Erturk FY; Kahveci R; Gokgoz S J Pak Med Assoc; 2013 Jul; 63(7):878-81. PubMed ID: 23901713 [TBL] [Abstract][Full Text] [Related]
12. Incidence of precancerous lesions in breast reduction tissue: a pathologic review of 562 consecutive patients. Clark CJ; Whang S; Paige KT Plast Reconstr Surg; 2009 Oct; 124(4):1033-1039. PubMed ID: 19935286 [TBL] [Abstract][Full Text] [Related]
13. Differentiated precursor lesions and low-grade variants of squamous cell carcinomas are frequent findings in foreskins of patients from a region of high penile cancer incidence. Oertell J; Caballero C; Iglesias M; Chaux A; Amat L; Ayala E; Rodríguez I; Velázquez EF; Barreto JE; Ayala G; Cubilla AL Histopathology; 2011 May; 58(6):925-33. PubMed ID: 21585428 [TBL] [Abstract][Full Text] [Related]
14. Histopathologic findings in breast reduction specimens. Kececi Y; Tasli FA; Yagcı A; Sır E; Canpolat S; Vardar E J Plast Surg Hand Surg; 2014 Apr; 48(2):122-5. PubMed ID: 23879776 [TBL] [Abstract][Full Text] [Related]
15. Current findings in the pathological evaluation of breast reduction specimens. Cruz NI; Guerrero A; González CI Bol Asoc Med P R; 1989 Oct; 81(10):387-9. PubMed ID: 2610788 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic analysis of breast lesions associated with multiple papillomas. Ali-Fehmi R; Carolin K; Wallis T; Visscher DW Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557 [TBL] [Abstract][Full Text] [Related]
17. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793 [TBL] [Abstract][Full Text] [Related]
19. [Node status in 454 ductal breast cancers cases according to the association with in situ component]. Carabias-Meseguer P; Cusidó-Gimferrer M; Zapardiel-Gutiérrez I; Tresserra-Casas F; Fábregas-Xauradó R; Xercavins-Montoya J Ginecol Obstet Mex; 2011 Jan; 79(1):5-10. PubMed ID: 21966777 [TBL] [Abstract][Full Text] [Related]
20. Should we be analysing breast reduction specimens? A systematic analysis of over 1,000 consecutive cases. Hassan FE; Pacifico MD Aesthetic Plast Surg; 2012 Oct; 36(5):1105-13. PubMed ID: 22678135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]